ClinicalMetric / Countries / Australia / pancreatic cancer
← 🇦🇺 Australia Trials
🇦🇺 Australia Country × Condition

pancreatic cancer Clinical Trials in Australia

Active clinical trials for pancreatic cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia

Active Trials in Australia (3)

NCT04075305
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment
8,000 pts
Country
🇦🇺 Australia
UMC Utrecht
View Trial →
NCT07491445 Phase 3
Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Enrollment
900 pts
Country
🇦🇺 Australia
Revolution Medicines, Inc.
View Trial →
NCT06910657 Phase 1
Recruiting

IDOV-Immune for Advanced Solid Tumors

Enrollment
78 pts
Country
🇦🇺 Australia
ViroMissile, Inc.
View Trial →

Frequently Asked Questions

How many pancreatic cancer clinical trials are active in Australia?
There are currently 3 active clinical trials for pancreatic cancer with sites in Australia, of which 3 are actively recruiting patients.
How can I join a pancreatic cancer clinical trial in Australia?
To join a pancreatic cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic cancer trials in Australia?
Active pancreatic cancer trials in Australia span Phase 3, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Australia Trials → Global pancreatic cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology